Tag: Lord Mancroft

The below Parliamentary question was asked by Lord Mancroft on 2016-03-23.

To ask Her Majesty’s Government whether plans to introduce a hepatitis C improvement framework have been abandoned and, if so, why.

Lord Prior of Brampton

NHS England has been rapidly working on their plans for access to treatment during 2016/17 following enactment of the National Institute for Health and Care Excellence technical appraisal guidance and has committed to produce an operational framework for the treatment of hepatitis C during 2016/17. This will set out NHS England’s commitment to improving outcomes in hepatitis C across England.

The below Parliamentary question was asked by Lord Mancroft on 2015-12-16.

To ask Her Majesty’s Government what steps they are taking to ensure that NHS England and Public Health England provide data demonstrating that there is equitable access to the new hepatitis C treatment.

Lord Prior of Brampton

Public Health England is working with NHS England and the Clinical Leads of the Operational Delivery Networks to ensure that a minimum data set is collected to allow monitoring of patients being treated. Limited demographic information will be requested to help interpret this information in the context of the whole infected population to help assess whether treatment access is as equitable as possible.

The below Parliamentary question was asked by Lord Mancroft on 2016-03-23.

To ask Her Majesty’s Government what plans they have to ensure that the objectives of the hepatitis C improvement framework can still be achieved.

Lord Prior of Brampton

NHS England has been rapidly working on their plans for access to treatment during 2016/17 following enactment of the National Institute for Health and Care Excellence technical appraisal guidance and has committed to produce an operational framework for the treatment of hepatitis C during 2016/17. This will set out NHS England’s commitment to improving outcomes in hepatitis C across England.

The below Parliamentary question was asked by Lord Mancroft on 2015-12-16.

To ask Her Majesty’s Government how they plan to measure the effectiveness of the implementation of the new medicines for hepatitis C treatment, and when they will publish those results.

Lord Prior of Brampton

NHS England has advised that it is working with Public Health England and the clinical leads of the operational delivery networks to agree a common dataset which will enable the effectiveness of new medicines for hepatitis C to be measured.

The below Parliamentary question was asked by Lord Mancroft on 2016-04-13.

To ask Her Majesty’s Government on which specific NICE guidance NHS England based its decision to restrict access to new treatments for hepatitis C to 10,000 patients in 2016–17.

Lord Prior of Brampton

The planning approach for hepatitis C is set out in the National Institute for Health and Care Excellence (NICE) Technology Appraisals 363, 364 and 365 which require Operational Delivery Networks to prioritise treatment for patients with the highest unmet clinical need. We understand from NHS England that the figure of 10,000 patients reflects NICE modelling used for its recommendations and published alongside the guidance.

The below Parliamentary question was asked by Lord Mancroft on 2016-02-09.

To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 4 January (HL4665) about access to hepatitis C treatment, how frequently NHS England will publish reports on the minimum data set and when the first set of data on patients being treated will be published.

Lord Prior of Brampton

Public Health England (PHE) is working with NHS England and the Clinical Leads of the Operational Delivery Networks to ensure that a minimum data set is collected to allow monitoring of patients being treated. This will be used to support commissioning and planning of these services. PHE plans to publish summary data on people being treated in the annual report on hepatitis C. No timetable for publication has been agreed.

The below Parliamentary question was asked by Lord Mancroft on 2016-04-13.

To ask Her Majesty’s Government whether NHS England’s decision to treat 10,000 hepatitis C patients represents a cap on the number of patients the NHS can treat in 2016–17.

Lord Prior of Brampton

NHS England’s approach paces the roll-out of hepatitis C treatment in accordance with the National Institute for Health and Care Excellence (NICE) recommendation for prioritisation and the modelling assumptions which informed the NICE recommendations.